Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe M Loiseau

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
European Journal of Medicinal Chemistry|November 5, 2020
In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibitionMarc-Antoine Bazin, Sandrine Cojean, Fabrice Pagniez, et al.
RSC Medicinal Chemistry|June 23, 2025
Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-<i>a</i>]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapyLhana Tisseur, Cédric Logé, Sandrine Cojean, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 18, 2025
Re-sensitization of antimony-resistant Leishmania by highly potent Sb<sup>V</sup>-porphyrin through the involvement of ERG6-coding geneEllen Gonçalves de Oliveira, Juliane Sousa Lanza, Sandrine Cojean, et al.
Scientific Reports|November 16, 2017
ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartmentsYu Wu, Valérie Pons, Amélie Goudet, et al.
Chemico-Biological Interactions|October 8, 2016
Inhibitors of retrograde trafficking active against ricin and Shiga toxins also protect cells from several viruses, Leishmania and ChlamydialesNeetu Gupta, Romain Noël, Amélie Goudet, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
European Journal of Medicinal Chemistry|November 5, 2020
In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibitionMarc-Antoine Bazin, Sandrine Cojean, Fabrice Pagniez, et al.
RSC Medicinal Chemistry|June 23, 2025
Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-<i>a</i>]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapyLhana Tisseur, Cédric Logé, Sandrine Cojean, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 18, 2025
Re-sensitization of antimony-resistant Leishmania by highly potent Sb<sup>V</sup>-porphyrin through the involvement of ERG6-coding geneEllen Gonçalves de Oliveira, Juliane Sousa Lanza, Sandrine Cojean, et al.
Scientific Reports|November 16, 2017
ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartmentsYu Wu, Valérie Pons, Amélie Goudet, et al.
Chemico-Biological Interactions|October 8, 2016
Inhibitors of retrograde trafficking active against ricin and Shiga toxins also protect cells from several viruses, Leishmania and ChlamydialesNeetu Gupta, Romain Noël, Amélie Goudet, et al.
Pageof 12